在慢性阻塞性肺病恶化后,长期心血管风险增加
Nathaniel M Hawkins1, Clementine Nordon2, Kirsty Rhodes2
1Centre for Cardiovascular Innovation, Division of Cardiology, The University of British Columbia, Vancouver, British Columbia, Canada nat.hawkins@ubc.ca.
Heart (British Cardiac Society)
|January 5, 2024
概括
慢性阻塞性肺病 (COPD) 的恶化显著增加心血管不良事件的风险,特别是心力衰竭. 及时的医疗照顾和优化COPD管理对于改善心血管结果至关重要.
科学领域:
- 心脏病学 心脏病学
- 肺部病理学 肺部病理学
- 流行病学 流行病学
背景情况:
- 慢性阻塞性肺病 (COPD) 恶化与增加的发病率和死亡率有关.
- 需要进一步调查COPD恶化对心血管 (CV) 的影响.
研究的目的:
- 调查COPD恶化和随后心血管不良事件的风险之间的关联.
- 量化特定心血管事件的风险,包括全因死亡,急性冠状动脉综合征,心力衰竭和脑缺血.
主要方法:
- 使用加拿大阿尔伯塔省 (2014-2019) 的行政数据进行的回顾性队列研究.
- 确定了COPD患者,并分析了中度或重度恶化后的时期.
- 利用时间依赖的考克斯回归来估计复合CV结果和单个事件的调整风险.
主要成果:
- 总共有1,427,787名COPD患者被纳入;43.4%的人至少经历过一次恶化.
- 慢性肺炎恶化显著增加了心血管不良事件的风险,在恶化后的第一周内,调整后的危险比率 (HR) 高达15.86.
- 心力衰竭 (HF) 脱补偿显示,在恶化后的1-7天内,心力衰竭 (HF) 脱补偿的风险增加最高 (HR 72.34).
结论:
- 中度和严重的COPD恶化是不良心血管事件的独立风险因素.
- 心力衰竭失补偿是COPD恶化后特别高风险的事件.
- 进一步的研究应该评估优化COPD管理策略对心血管结果的影响.
相关概念视频
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
COPD: Pathogenesis and Clinical Features
279
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
279
COPD: Management Using Bronchodilators and Corticosteroids
208
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
208


